FR2959414B1 - Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire - Google Patents

Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire

Info

Publication number
FR2959414B1
FR2959414B1 FR1053355A FR1053355A FR2959414B1 FR 2959414 B1 FR2959414 B1 FR 2959414B1 FR 1053355 A FR1053355 A FR 1053355A FR 1053355 A FR1053355 A FR 1053355A FR 2959414 B1 FR2959414 B1 FR 2959414B1
Authority
FR
France
Prior art keywords
refractory
volemie
cardiogenic
asthmatic
anaphylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1053355A
Other languages
English (en)
Other versions
FR2959414A1 (fr
Inventor
Luc Quintin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1053355A priority Critical patent/FR2959414B1/fr
Priority to US13/168,889 priority patent/US8846606B2/en
Publication of FR2959414A1 publication Critical patent/FR2959414A1/fr
Application granted granted Critical
Publication of FR2959414B1 publication Critical patent/FR2959414B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR1053355A 2010-04-30 2010-04-30 Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire Expired - Fee Related FR2959414B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1053355A FR2959414B1 (fr) 2010-04-30 2010-04-30 Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
US13/168,889 US8846606B2 (en) 2010-04-30 2011-06-24 Method and drug composition for treating septic shock hypotension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1053355A FR2959414B1 (fr) 2010-04-30 2010-04-30 Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire

Publications (2)

Publication Number Publication Date
FR2959414A1 FR2959414A1 (fr) 2011-11-04
FR2959414B1 true FR2959414B1 (fr) 2016-01-08

Family

ID=43086528

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1053355A Expired - Fee Related FR2959414B1 (fr) 2010-04-30 2010-04-30 Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire

Country Status (2)

Country Link
US (1) US8846606B2 (fr)
FR (1) FR2959414B1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
WO2015089494A1 (fr) * 2013-12-13 2015-06-18 Ankenman Ralph Compositions et méthodes pour le traitement de systèmes déréglés
CN112546197A (zh) * 2013-12-18 2021-03-26 乔治华盛顿大学国会特许非营利公司 血管紧张素ii单独或以组合方式用于治疗低血压
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CN113164550A (zh) * 2018-11-15 2021-07-23 费灵有限公司 用于治疗败血症的化合物、组合物和方法

Also Published As

Publication number Publication date
US20110269666A1 (en) 2011-11-03
US8846606B2 (en) 2014-09-30
FR2959414A1 (fr) 2011-11-04

Similar Documents

Publication Publication Date Title
FR2959414B1 (fr) Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
LTPA2017019I1 (lt) Žmogaus antikūnai, pasižymintys dideliu giminingumu PCSK9
CY2016030I2 (el) Αντισωματα εναντι της il-17
DE502006004066D1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP2279003A4 (fr) Anticorps anti-cd137 en tant qu'agent dans le traitement d'états inflammatoires
CY2016017I2 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
FR2928832B1 (fr) Orthese de poignet, destinee au traitement du syndrome du canal carpien
DK1889065T3 (da) Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
MA29098B1 (fr) Compositions pour le traitement du vhc
FR2929661B1 (fr) Retenue axiale d'aubes de compresseur.
MA34263B1 (fr) Marqueurs de prédiction utiles dans traitement du syndrome de l'x fragile (fxs)
FR2929946B1 (fr) Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
SMT201400177B (it) Diagnosi e trattamenti di carcinoma basati sul genotipo di odc1
DK2107870T3 (da) Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom
BRPI0923220A2 (pt) dispositivo e processo de fabricação de uma lona de reforço.
DK3326681T3 (da) Indretning til behandling af analsphincteren
BRPI0909895A2 (pt) "sistema iniciador e composição endurecível"
LTPA2016019I1 (lt) Išsėtinės sklerozės (MS) gydymas kampatu-1H
DE602006004175D1 (de) Gerät zur Bestimmung der Keulenrichtung
DK2328553T3 (da) Corticosteroider til behandling af inflammatoriske sygdomme i mave-tarm-kanalen
DE602006021105D1 (de) Nachbehandlung eines Abgasstroms
DE502006007167D1 (de) Gehäuse für eine abgasbehandlungskomponente mit verstärkungshülse
RU2009133559A (ru) Способ обработки деталей

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

CA Change of address

Effective date: 20160906

ST Notification of lapse

Effective date: 20171229